REPORT ID 2220

Global Opioids Drug Market 2017 Industry Research Report

Publish Date
8-Dec-17
Pages
154
Format
Electronic (PDF)

In the last several years, Global market of Opioids Drug developed smoothly, with an average growth rate of 0.7%. In 2016, Global Revenue of Opioids Drug is nearly 11300 M USD; the actual production is about 10.17 billion Unit.

This report studies Opioids Drug in Global market, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm

Geographically, this report is segmented into several key regions, with production, revenue, market share (%) and growth Rate (%) of Opioids Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia (Ex. China)
China
Other

On the basis of product, the Opioids Drug market is primarily split into 
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other

On the basis on the end users/applications, this report covers 
Pain Relief
Anesthesia
Other


 
 
			   
Table of Contents

1 Opioids Drug Market Overview	1
1.1 Product Overview and Scope of Opioids Drug	1
1.2 Opioids Drug Segment by Type	2
1.2.1 Global Opioids Drug Production and Growth Rate Comparison by Types (2012-2022)	2
1.2.2 Global Opioids Drug Production Market Share by Types in 2016	2
1.2.3 Oxycodone	3
1.2.4 Hydromorphone	3
1.2.5 Codeine	4
1.2.6 Fentanyl	4
1.3 Opioids Drug Segment by Application	5
1.3.1 Global Opioids Drug Consumption Comparison by Applications (2012-2022)	5
1.3.2 Pain Relief	6
1.3.3 Anesthesia	6
1.4 Global Opioids Drug Market by Regions (2012-2022)	7
1.4.1 Global Opioids Drug Market Size and Growth Rate Comparison by Regions (2012-2022)	7
1.4.2 North America Opioids Drug Status and Prospect (2012-2022)	8
1.4.3 China Opioids Drug Status and Prospect (2012-2022)	9
1.4.4 Europe Opioids Drug Status and Prospect (2012-2022)	9
1.4.5 Asia (Ex.China) Opioids Drug Status and Prospect (2012-2022)	10
1.5 Global Opioids Drug Market Size (2012-2022)	11
1.5.1 Global Opioids Drug Revenue Status and Outlook (2012-2022)	11
1.5.2 Global Opioids Drug Production Status and Outlook (2012-2022)	12
2 Global Opioids Drug Market Competition by Manufacturers	13
2.1 Global Opioids Drug Production and Share by Manufacturers (2016-2017)	13
2.2 Global Opioids Drug Revenue and Share by Manufacturers (2016-2017)	15
2.3 Global Opioids Drug Average Price by Manufacturers (2016-2017)	18
2.4 Manufacturers Opioids Drug Headquarters, Established Date	20
2.5 Opioids Drug Market Competitive Situation and Trends	21
2.5.1 Opioids Drug Market Concentration Rate	21
2.5.2 Opioids Drug Market Share of Top 3 and Top 5 Manufacturers	22
2.5.3 Mergers & Acquisitions, Expansion	23
3 Global Opioids Drug Production by Regions (2012-2017)	25
3.1 Global Opioids Drug Production and Market Share by Regions (2012-2017)	25
3.2 Global Opioids Drug Revenue and Market Share by Regions (2012-2017)	27
3.3 Global Opioids Drug Production, Revenue, Price and Gross Margin (2012-2017)	29
3.4 North America Opioids Drug Production (2012-2017)	30
3.4.1 North America Opioids Drug Production and Growth Rate (2012-2017)	30
3.4.2 North America Opioids Drug Production, Revenue, Price and Gross Margin (2012-2017)	30
3.5 Europe Opioids Drug Production (2012-2017)	31
3.5.1 Europe Opioids Drug Production and Growth Rate (2012-2017)	31
3.5.2 Europe Opioids Drug Production, Revenue, Price and Gross Margin (2012-2017)	31
3.6 China Opioids Drug Production (2012-2017)	32
3.6.1 China Opioids Drug Production and Growth Rate (2012-2017)	32
3.6.2 China Opioids Drug Production, Revenue, Price and Gross Margin (2012-2017)	32
3.7 Asia (Ex.China) Opioids Drug Production (2012-2017)	33
3.7.1 Asia (Ex.China) Opioids Drug Production and Growth Rate (2012-2017)	33
3.7.2 Asia (Ex.China) Opioids Drug Production, Revenue, Price and Gross Margin (2012-2017)	33
4 Global Opioids Drug Consumption by Regions (2012-2017)	34
4.1 Global Opioids Drug Consumption by Regions (2012-2017)	34
4.2 North America Opioids Drug Consumption (2012-2017)	36
4.3 Europe Opioids Drug Consumption (2012-2017)	37
4.4 China Opioids Drug Consumption (2012-2017)	38
4.5 Asia (Ex.China) Opioids Drug Consumption (2012-2017)	39
5 Global Opioids Drug Production, Revenue (Value), Price Trend by Types	40
5.1 Global Opioids Drug Production and Market Share by Types (2012-2017)	40
5.2 Global Opioids Drug Revenue and Market Share by Types (2012-2017)	42
5.3 Global Opioids Drug Price by Type (2012-2017)	44
5.4 Global Opioids Drug Production Growth by Type (2012-2017)	44
6 Global Opioids Drug Market Analysis by Applications	45
6.1 Global Opioids Drug Consumption and Market Share by Applications (2012-2017)	45
6.2 Global Opioids Drug Consumption Growth Rate by Applications (2012-2017)	47
7 Analysis of Opioids Drug Industry Key Manufacturers	48
7.1 Purdue Pharma	48
7.1.1 Company Profile	48
7.1.2 Product Information	49
7.1.3 Production, Price, Cost, Gross, and Revenue	49
7.2 J&J	50
7.2.1 Company Profile	50
7.2.2 Product Information	51
7.2.3 Production, Price, Cost, Gross, and Revenue	52
7.3 Teva	52
7.3.1 Company Profile	52
7.3.2 Product Information	54
7.3.3 Production, Price, Cost, Gross, and Revenue	54
7.4 Mylan	55
7.4.1 Company Profile	55
7.4.2 Product Information	56
7.4.3 Production, Price, Cost, Gross, and Revenue	56
7.5 Depomed	57
7.5.1 Company Profile	57
7.5.2 Product Information	58
7.5.3 Production, Price, Cost, Gross, and Revenue	58
7.6 INSYS Therapeutics	59
7.6.1 Company Profile	59
7.6.2 Product Information	60
7.6.3 Production, Price, Cost, Gross, and Revenue	60
7.7 Endo Pharmaceuticals	61
7.7.1 Company Profile	61
7.7.2 Product Information	62
7.7.3 Production, Price, Cost, Gross, and Revenue	62
7.8 Pfizer	63
7.8.1 Company Profile	63
7.8.2 Product Information	64
7.8.3 Production, Price, Cost, Gross, and Revenue	65
7.9 Hikma Pharmaceuticals	65
7.9.1 Company Profile	65
7.9.2 Product Information	66
7.9.3 Production, Price, Cost, Gross, and Revenue	66
7.10 Mallinckrodt	67
7.10.1 Company Profile	67
7.10.2 Product Information	68
7.10.3 Production, Price, Cost, Gross, and Revenue	68
7.11 Pernix	69
7.11.1 Company Profile	69
7.11.2 Product Information	70
7.11.3 Production, Price, Cost, Gross, and Revenue	70
7.12 Egalet	71
7.12.1 Company Profile	71
7.12.2 Product Information	72
7.12.3 Production, Price, Cost, Gross, and Revenue	72
7.13 Vistapharm	73
7.13.1 Company Profile	73
7.13.2 Product Information	74
7.13.3 Production, Price, Cost, Gross, and Revenue	74
8 Opioids Drug Manufacturing Cost Analysis	75
8.1 Opioids Drug Key Raw Materials Analysis	75
8.1.1 Key Raw Materials	75
8.1.2 Price Trend of Key Raw Materials	76
8.1.3 Key Suppliers of Raw Materials	76
8.1.4 Market Concentration Rate of Raw Materials	77
8.2 Proportion of Manufacturing Cost Structure	78
8.2.1 Raw Materials	78
8.2.2 Labor Cost	78
8.2.3 Other Costs Analysis	85
8.3 Manufacturing Process Analysis of Opioids Drug	89
9 Industrial Chain, Sourcing Strategy and Downstream Buyers	91
9.1 Opioids Drug Industrial Chain Analysis	91
9.2 Upstream Raw Materials Sourcing	92
9.3 Downstream Buyers	92
10 Marketing Strategy Analysis, Distributors/Traders	95
10.1 Marketing Channel	95
10.1.1 Direct Marketing	95
10.1.2 Indirect Marketing	95
10.1.3 Marketing Channel Development Trend	95
10.2 Market Positioning	96
10.2.1 Pricing Strategy	96
10.2.2 Brand Strategy	97
10.2.3 Target Client	98
10.3 Distributors/Traders List	99
10.3.1 CVS Company Profile	99
10.3.2 Walgreen Company Profile	100
10.3.3 Rite Aid Company Profile	101
10.3.4 Loblaw Company Profile	102
10.3.5 Diplomat Company Profile	103
10.3.6 Ahold Company Profile	104
10.3.7 AinPharmaciez Company Profile	105
10.3.8 Guoda Drugstore Company Profile	106
10.3.9 Yixintang Company Profile	107
10.3.10 Albertsons Company Profile	108
11 Market Effect Factors Analysis	110
11.1 Technology Progress/Risk	110
11.1.1 Substitutes Threat	110
11.1.2 Technology Progress in Related Industry	110
11.2 Consumer Needs/Customer Preference Change	111
11.3 Economic/Political Environmental Change	111
12 Global Opioids Drug Market Forecast (2017-2022)	117
12.1 Global Opioids Drug Production, Revenue Forecast (2017-2022)	117
12.1.1 Global Opioids Drug Production and Growth Rate Forecast (2017-2022)	117
12.1.2 Global Opioids Drug Revenue and Growth Rate Forecast (2017-2022)	118
12.2 Global Opioids Drug Production Forecast by Regions (2017-2022)	118
12.2.1 North America Opioids Drug Production and Revenue Forecast (2017-2022)	119
12.2.2 Europe Opioids Drug Production, Revenue Forecast (2017-2022)	121
12.2.3 China Opioids Drug Production, Revenue Forecast (2017-2022)	122
12.2.4 Asia (Ex.China) Opioids Drug Production, Revenue Forecast (2017-2022)	123
12.3 Global Opioids Drug Consumption Forecast by Regions (2017-2022)	124
12.3.1 North America Opioids Drug Consumption Forecast (2017-2022)	125
12.3.2 Europe Opioids Drug Consumption Forecast (2017-2022)	126
12.3.3 China Opioids Drug Consumption Forecast (2017-2022)	127
12.3.4 Asia (Ex.China) Opioids Drug Consumption Forecast (2017-2022)	128
12.4 Global Opioids Drug Production, Revenue Forecast by Type (2017-2022)	128
12.5 Global Opioids Drug Consumption Forecast by Application (2017-2022)	130
13 Research Findings and Conclusion	132
14 Appendix	133
14.1 Methodology/Research Approach	133
14.1.1 Research Programs/Design	133
14.1.2 Market Size Estimation	134
14.1.3 Market Breakdown and Data Triangulation	135
14.2 Data Source	136
14.2.1 Secondary Sources	136
14.2.2 Primary Sources	137
14.3 Disclaimer	138
14.4 Author List	140